sar425899 sanofi dual glp-1 glucagon agonist Media Centre The current significance and prospects
Description
Accepted: May 13, 2024 DOI: Download citation
Ozempic and Zepbound both contain the active ingredient semaglutide, which is a GLP-1 receptor agonist
Nevertheless, none of the published studies have provided information on fracture-related outcomes
In addition, it inhibits the inflammatory effect of nuclear factor (NF)-B (96) and inhibits the growth and metastasis of pancreatic cancer cells
